| Ref ID | 695 |
| First Author | P. Liu |
| Journal | CLINICAL TRIALS |
| Year Of Publishing | 2020 |
| URL | https://dx.doi.org/10.1177/1740774519887148 |
| Keywords |
• General medical • Cochrane • Equity |
| Problem(s) |
• Failure to consider equity, different socioeconomic groups or disadvantaged populations |
| Article Type | Editorial |
| Article Subtype | Comment/letter |
| First Author Country | United States |
| Aim | A research letter highlighting a random sample of Cochrane reviews' use of race and ethnicity subgroup analyses, as potentially relevant treatment effect modifiers. Reviews were conducted between 2000-2018. |
| Level of Investigation | Descriptive |
| Summary of Findings | Only 14 (1.5%) of the 928 Cochrane reviews sampled outlined plans to conduct race or ethnicity subgroup analyses. Of these, Nearly all (13/14, 92.9%) of the planned analyses were not conducted, primarily due to insufficient data. |
| Number of systematic reviews included | 928 |
| Number of eligible systematic reviews assessed | 9518 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |